中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

65岁及以上老年肝脏肿瘤患者个体化射频消融治疗经验总结

江华 王悦华 刘家峰 刘东斌 郑亚民

引用本文:
Citation:

65岁及以上老年肝脏肿瘤患者个体化射频消融治疗经验总结

DOI: 10.3969/j.issn.1001-5256.2020.02.035
基金项目: 

教育部人文社会科学研究项目(14YJAZH083); 

详细信息
  • 中图分类号: R735.7

Experience of individualized radiofrequency ablation in patients aged 65 years or older with liver tumors

Research funding: 

 

  • 摘要:

    <正>随着社会老龄化,65岁以上老年肝脏肿瘤患者亦逐渐增多,此类疾病的治疗很大程度上取决于患者的总体状况。在某些有合并症的老年患者中,行肝癌根治性切除手术及肝移植并不适合[1],射频治疗为这些不适合立即行肝脏根治性肿瘤切除术的患者提供了一种替代治疗方法,并于2009年被美国国立综合癌症网络肝癌治疗指南列为肿瘤根治性治疗方法之一,具有疗效确切、局部创伤小等优点。然而,目前关于射频治疗作为开腹手术的有效替代方法的经验仍然不十分充分,仍有严重并发症报道。本研究总结了近13年来本院老年肝脏肿瘤患者进行射频治疗的经验。

     

  • [1] Organ Transplantation Branch,Chinese Medical Doctor Association; Chinese Society of Organ Transplantation,Chinese Medical Association. The Chinese clinical practice guideline on liver transplantation for hepatocellular carcinoma(2018)[J]. J Clin Hepatol,2019,35(2):275-280.(in Chinese)中国医师协会器官移植医师分会,中华医学会器官移植学分会.中国肝癌肝移植临床实践指南(2018版)[J].临床肝胆病杂志,2019,35(2):275-280.
    [2] Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC), Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology. Guidelines for radiofrequency ablation therapy of liver cancer[J]. J Clin Hepatol,2011,27(3):236-238,244.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作委员会,中华医学会肝病学分会肝癌学组.肝癌射频消融治疗规范的专家共识[J].临床肝胆病杂志,2011,27(3):236-238,244.
    [3] ZENG XX. Research advances in frailty index,a comprehensive index for elderly health[J]. Chin J Gerontol,2010,30(21):3220-3223.(in Chinese)曾宪新.老年健康综合指标———虚弱指数研究进展[J].中国老年学杂志,2010,30(21):3220-3223.
    [4] GANI F,CERULLO M,AMINI N,et al. Frailty as a risk predictor of morbidity and mortality following liver surgery[J]. J Gastrointest Surg,2017,21(5):822-830.
    [5] FORTNER JG,LINCER RM. Hepatic resection in the elderly[J]. Ann Surg,1990,211(2):141-145.
    [6] CUCCHETTI A,PISCAGLIA F,CESCON M,et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma[J]. J Hepatol,2013,59(2):300-307.
    [7] CABIBBO G,ANTONUCCI M,SACCO R,et al. Ultrasound-guided ablation for hepatocellular carcinoma:Time for a reappraisal?[J]. Expert Rev Anticancer Ther,2015,15(2):147-150.
    [8] SMITH TJ,MANSKE JG,MATHIASON MA,et al. Changing trends and outcomes in the use of percutaneous cholecystostomy tubes for acute cholecystitis[J]. Ann Surg,2013,257(6):1112-1115.
    [9] CHA DI,LEE MW,RHIM H,et al. Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations[J]. Korean J Radiol,2013,14(2):240-247.
  • 加载中
计量
  • 文章访问数:  744
  • HTML全文浏览量:  9
  • PDF下载量:  188
  • 被引次数: 0
出版历程
  • 出版日期:  2020-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回